123 related articles for article (PubMed ID: 11068992)
41. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.
Cubukcu E; Kanat O; Fatih Olmez O; Kabul S; Canhoroz M; Avci N; Deligonul A; Hartavi M; Cubukcu S; Olmez F; Kurt E; Evrensel T; Gokgoz S; Manavoglu O
J BUON; 2013; 18(2):359-65. PubMed ID: 23818346
[TBL] [Abstract][Full Text] [Related]
42. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
Rodrigues NA; Dillon D; Carter D; Parisot N; Haffty BG
Cancer; 2003 Mar; 97(6):1393-403. PubMed ID: 12627502
[TBL] [Abstract][Full Text] [Related]
43. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.
Zafrani B; Leroyer A; Fourquet A; Laurent M; Trophilme D; Validire P; Sastre-Garau X
Semin Diagn Pathol; 1994 Aug; 11(3):208-14. PubMed ID: 7831532
[TBL] [Abstract][Full Text] [Related]
44. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
[TBL] [Abstract][Full Text] [Related]
45. Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):370-7. PubMed ID: 23249701
[TBL] [Abstract][Full Text] [Related]
46. Sebaceous carcinoma of the eyelids: a review of 21 cases.
Saito A; Tsutsumida A; Furukawa H; Saito N; Yamamoto Y
J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1328-31. PubMed ID: 17974515
[TBL] [Abstract][Full Text] [Related]
47. Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression.
Kolár Z; Murray PG; Zapletalová J
Neoplasma; 2002; 49(2):110-3. PubMed ID: 12088102
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological analysis of periocular sebaceous gland carcinoma.
Yoon JS; Kim SH; Lee CS; Lew H; Lee SY
Ophthalmologica; 2007; 221(5):331-9. PubMed ID: 17728556
[TBL] [Abstract][Full Text] [Related]
49. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
[TBL] [Abstract][Full Text] [Related]
50. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
Wilbur DC; Barrows GH
Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
52. Sebaceous gland and sweat gland carcinomas of the skin. Clinicopathological study and significance of c-erbB-2 oncoprotein expression.
Hasebe T; Mukai K; Ishihara K; Kaneko A; Shimosato Y
Acta Pathol Jpn; 1992 Aug; 42(8):585-94. PubMed ID: 1360186
[TBL] [Abstract][Full Text] [Related]
53. Sebaceous carcinoma of the eyelids: thirty cases from Japan.
Izumi M; Mukai K; Nagai T; Matsubayashi J; Iwaya K; Chiu CS; Goto H
Pathol Int; 2008 Aug; 58(8):483-8. PubMed ID: 18705767
[TBL] [Abstract][Full Text] [Related]
54. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
55. c-erbB-2, p53 protein expression and steroid hormone receptors in breast carcinomas: an immunohistochemical study.
Yokota T; Imamura M; Teshima S; Suzuki H; Tezuka F; Kikuchi S; Kunii Y; Yamauchi H
Anticancer Res; 1999; 19(5B):4007-12. PubMed ID: 10628345
[TBL] [Abstract][Full Text] [Related]
56. Sebaceous carcinoma of the eyelids.
Karcioglu ZA
Ophthalmology; 2005 Sep; 112(9):1641; author reply 1641-2. PubMed ID: 16139675
[No Abstract] [Full Text] [Related]
57. Dermoscopic features of ocular and extraocular sebaceous carcinomas.
Satomura H; Ogata D; Arai E; Tsuchida T
J Dermatol; 2017 Nov; 44(11):1313-1316. PubMed ID: 28631273
[TBL] [Abstract][Full Text] [Related]
58. [Immunohistochemical characteristics of mammary carcinomas with estrogen-negative and progesterone-positive receptors].
Sundblad AS; Caprarulo L
Medicina (B Aires); 1996; 56(6):683-9. PubMed ID: 9284572
[TBL] [Abstract][Full Text] [Related]
59. Highly aggressive extraocular sebaceous carcinoma.
Moreno C; Jacyk WK; Judd MJ; Requena L
Am J Dermatopathol; 2001 Oct; 23(5):450-5. PubMed ID: 11801779
[TBL] [Abstract][Full Text] [Related]
60. Sebaceous gland carcinoma. Review of 40 cases.
Doxanas MT; Green WR
Arch Ophthalmol; 1984 Feb; 102(2):245-9. PubMed ID: 6696670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
